Literature DB >> 17122632

An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer.

Dinesh S Rao1, Dorina Gui, Michelle E Koski, Laura M Popoviciu, Hejing Wang, Robert E Reiter, Jonathan W Said.   

Abstract

The identification of biomarkers in prostatic carcinoma has yielded important data regarding prognosis and has aided in increasing diagnostic accuracy. Additionally, this approach has yielded important insights into the biology of prostatic carcinoma. In this study, we report that the expression of the cyclooxygenase isoenzyme, COX-2, is significantly increased in prostatic carcinoma, whereas that of the cell adhesion molecule, E-cadherin, is decreased. The expression of COX-2 was positively correlated with higher tumor stage, and the presence of carcinoma in surgical margins at prostatectomy. Conversely, the expression of E-cadherin was inversely related to these prognostic indicators. Lastly, the expressions of COX-2 and E-cadherin were very strongly and inversely correlated. These results provide important insights into the biologic underpinnings of prostate carcinoma; and further studies into COX-2 expression in prostate core biopsies may show utility in preprostatectomy prognostication. Furthermore, these results may provide a rational basis for therapeutic intervention and chemoprevention with COX-2 inhibitor therapy in prostate carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122632     DOI: 10.1097/01.pai.0000210417.61117.6c

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  8 in total

1.  A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

Authors:  Melanie J Grubisha; M E Cifuentes; Stephen R Hammes; Donald B Defranco
Journal:  Mol Endocrinol       Date:  2012-05-16

2.  E-cadherin expression is inversely correlated with aging and inflammation in the prostate.

Authors:  Laura E Pascal; Rajiv Dhir; Goundappa K Balasubramani; Wei Chen; Chandler N Hudson; Pooja Srivastava; Anthony Green; Donald B DeFranco; Naoki Yoshimura; Zhou Wang
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

3.  Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Authors:  Aaron P Putzke; Aviva P Ventura; Alexander M Bailey; Canan Akture; John Opoku-Ansah; Müge Celiktaş; Michael S Hwang; Douglas S Darling; Ilsa M Coleman; Peter S Nelson; Holly M Nguyen; Eva Corey; Muneesh Tewari; Colm Morrissey; Robert L Vessella; Beatrice S Knudsen
Journal:  Am J Pathol       Date:  2011-05-04       Impact factor: 4.307

4.  Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells.

Authors:  Xiao-Jun Liu; Zhao-Feng Chen; Hai-Long Li; Ze-Nan Hu; Min Liu; Ai-Ping Tian; Da Zhao; Jing Wu; Yong-Ning Zhou; Liang Qiao
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 5.  Role of cyclooxygenase-2 in gastric cancer development and progression.

Authors:  Jian Cheng; Xiao-Ming Fan
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.

Authors:  William J Aronson; Naoko Kobayashi; R James Barnard; Susanne Henning; Min Huang; Patricia M Jardack; Bingrong Liu; Ashley Gray; Junxiang Wan; Ramdev Konijeti; Stephen J Freedland; Brandon Castor; David Heber; David Elashoff; Jonathan Said; Pinchas Cohen; Colette Galet
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-25

7.  p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer.

Authors:  Panagiotis J Vlachostergios; Foteini Karasavvidou; Anna Patrikidou; Ioannis A Voutsadakis; Grigorios Kakkas; George Moutzouris; Elias Zintzaras; Danai D Daliani; Michael D Melekos; Christos N Papandreou
Journal:  Pathol Oncol Res       Date:  2011-07-23       Impact factor: 3.201

Review 8.  Targeting Lipid Peroxidation for Cancer Treatment.

Authors:  Sofia M Clemente; Oscar H Martínez-Costa; Maria Monsalve; Alejandro K Samhan-Arias
Journal:  Molecules       Date:  2020-11-05       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.